Mumbai-based supplier ACG has signed a Memorandum of Understanding (MoU) with the Government of Maharashtra to set up Asia’s largest manufacturing plant cum R&D centre at Aurangabad in Maharashtra, to produce 40 billion capsules a year. The plant will serve both, Indian and international pharmaceutical and nutraceutical companies.
Karan Singh, Managing Director, ACG, said “Our proposed investment of approximately $ 100 million (over Rs 600 crores) in this state-of-the-art plant, is an integral part of ACG’s mission to double our capsule manufacturing capacity to 240 billion capsules a year.This plant will play a key role in further cementing India’s position as the global hub of capsule manufacturing and will add to improved access to high quality, safe and affordable medicines and nutraceuticals globally.”
Nitin Desai, Senior Vice President, ACG, said “When ready by 2023, it will create around 1000 direct and indirect jobs in the region.”
The plant will employ key design principles from the internationally recognized Leadership in Energy and Environmental Design (LEED) and will be powered significantly by green renewable energy to create and sustain value.
Setting new benchmarks for the industry, it will employ automation and industry 4.0 technologies to minimize resource intensity and ensure products meet and exceed the highest global manufacturing practices (GMP). Government of Maharashtra has accorded a ‘Mega Project’ status to this project.